Bizarre Patents
System for magnetically attaching templeless eyewear to a person
A system of eyewear that eliminates the need for hinges on the frames of the eyewear.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7205311 | Therapeutic acridone and acridine compounds This invention pertains to certain acridone and acridine compounds of the formula which inhibit telomerase, regulate cell proliferation, etc., and/or treat cancer, proliferative conditions, etc.: wherein either: (a) K is ═O, L is —H, alpha single bond, beta is a... | 04/17/2007 |
| 7145011 | Method for the production of substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acids The invention relates to a method for the production of substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acids, i.e. 7,9-dichlor-3a,4,5,9b-tetrahydro-3H-cyclopental[c]quinoline-4-carboxylic acid. ... | 12/05/2006 |
| 7129093 | Quantitative method of determining beryllium or a compound thereof in a sample A method of determining beryllium or a beryllium compound thereof in a sample, includes providing a sample suspected of comprising beryllium or a compound thereof, extracting beryllium or a compound thereof from the sample by dissolving in a solution, adding a fluor... | 10/31/2006 |
| 7109327 | Total synthesis of galanthamine, analogues and derivatives thereof The invention relates to a method for the synthesis of galanthamifle, the derivatives and analogues thereof of formula (1) where R1=a hydrogen atom. R2=a hydroxy group, R1 and R2 together form ═O, R3, R4 | 09/19/2006 |
| 7012144 | Quinolone carboxylic acid derivatives Quinolone carboxylic acid derivatives of formula (I) and pharmaceutically acceptable salts thereof have potent antibacterial activity: wherein, R1 is a C1-4 alkyl... | 03/14/2006 |
| 6991858 | Blue light-emitting compound for organic electroluminescent device and organic electroluminescent device using the same The present invention relates to a blue light-emitting compound for organic polymer EL devices and organic EL devices having superior color purity and light-emitting efficiency by providing a blue light-emitting compound for organic EL devices represented by Chemica... | 01/31/2006 |
| 6958347 | Aminophenanthridinone and aminophenanthridine as NPY-5 antagonists The present invention provides NPY-5 receptor antagonists having a Formula (I) Methods and pharmaceutical compositions useful for treating diseases, conditions and/or disorders modulated by the above NPY-5 receptor ant... | 10/25/2005 |
| 6894061 | Substituted dihydrophenanthridinesulfonamides This invention provides a compound of formulae (I) or (II) having the structure or a pharmaceutically acceptable salt thereof which are useful for the treatment of the inflammatory component of diseases and are particu... | 05/17/2005 |
| 6833455 | Bridged perinones/quinophthalones Disclosed herein are bridged perinones/quinophthalones of the general formula (I) or tautomeric forms thereof where X1, X2, Ar1 Ar2 and B are as described herein and are particularly characterized... | 12/21/2004 |
| 6699899 | Substituted acylhydroxamic acids and method of reducing TNF levels Imido and amido substituted acylhydroxamic acids which reduce the levels of TNF and inhibit phosphodiesterase in a mammal. A typical embodiment is (3-(1,3-dioxoisoindolin-2-yl)-3-(3-ethoxy-4-methoxyphenyl)propanoylamino)p ropanoate.... | 03/02/2004 |
| 6559308 | Method for preparing heterocyclic-carboxylic acids The present invention relates to a method for preparing quinoxaline-5- and 6-carboxylic acids. The method comprises contacting an aqueous suspension of a 5- or 6-hydroxymethyl quinoxaline with oxygen in the presence of a transition metal catalyst, to form... | 05/06/2003 |
| 6303569 | Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents The present invention is directed to double prodrugs containing polymeric-based transport forms. These polymeric compounds comprise the formula: ##STR1## wherein: B is H, OH, OSiR13, a residue of an amine-containing target moiety or a resi... | 10/16/2001 |
| 6288232 | Synthesis of pyrazolinylnaphthalic acid derivatives The invention pertains to a method for preparing derivatives of the pyrazolinylnaphthalic acid having the general formula ##STR1## where Ar1 and Ar2 are unsubstituted or substituted phenyl radicals bearing in the para position an alk... | 09/11/2001 |
| 6150375 | 5-reductase inhibitors A series of benzoquinolin-3-ones are pharmaceuticals effective in treating conditions consequent on both Type I and Type II 5-reductase.... | 11/21/2000 |
| 6130217 | Compounds enhancing antitumor activity of other cytotoxic agents This invention relates to certain heterocyclic compounds and their pharmaceutically acceptable salts, which are useful for sensitizing multidrug-resistant tumor cells to anticancer agents and multidrug resistant forms of malaria, tuberculosis, leishmania ... | 10/10/2000 |
| 6111110 | Synthesis of benzo[f]quinolinones A process for preparing intermediates and benzoquinolin-3-one pharmaceuticals, such pharmaceuticals are effective in treating conditions consequent on 5-reductase.... | 08/29/2000 |
| 6048869 | Tricyclic compounds The novel compounds of the present invention are those of structural formula I: ##STR1## or a pharmaceutically acceptable salt, ester, or stereoisomer thereof, which are inhibitors of 5-reductase. The compounds of formula I are useful in ... | 04/11/2000 |
| 6030967 | Naphtholactams and lactones as bone morphogenetic protein active agents A compound of the formula: wherein Q is an optionally substituted carbon atom or N(O)p wherein p is 0 or 1; Y is an optionally substituted methylene group, S(O)q wherein q is an integer of 0 to 2, or an optionally substituted imino group; Z1 is a C1... | 02/29/2000 |
| 6025408 | Liquid thioxanthone photoinitiators Novel thioxanthone derivatives and mixtures thereof and methods of making and using the same are disclosed. The novel thioxanthone derivatives can be liquid at room temperature and display highly active photoinitiation and photopolymerization properties.... | 02/15/2000 |
| 5986100 | Pharmaceutical compositions and methods for use A compound of the formula: ##STR1## wherein X' is nitrogen or carbon bonded to a substituent species characterized as having a sigma m value greater than 0, less than 0 or 0; X is nitrogen or carbon bonded to a substituent species characterized as ... | 11/16/1999 |
| 5968945 | Immunotherapeutic agents Novel amides and imides are inhibitors of tumor necrosis factor and phosphodiesterase and can be used to combat cachexia, endotoxic shock, retrovirus replication, asthma, and inflammatory conditions. Typical embodiments include 3-(1,3-dioxoben... | 10/19/1999 |
| 5968944 | Substituted pyrazoles as corticotropin-releasing factor (CRF) antagonists The compounds of the formula wherein A, R1, R3, X1, Y and Z are as defined herein, have corticotropin-releasing factor (CRF) antagonist activity. They are useful in the treatment of illnesses induced by CRF, such as stress... | 10/19/1999 |
| 5962469 | Cyclic nitrones The present invention is directed to novel cyclic nitrones and their use in the prevention of oxidation tissue damage by free radicals, their use in the treatment of a number of disease states in which radicals either damage or destroy tissues via oxidati... | 10/05/1999 |
| 5935272 | Compositions comprising aryloxypolyoxyalkylene naphthalimide derivative colorants This invention relates to compositions comprising naphthalimide derivative colorants themselves comprising naphthalimide backbones with specific water-solubilizing pendant moieties attached. These pendant moieties are based upon aryloxypolyoxyalkylene gro... | 08/10/1999 |
| 5925527 | Tricyclic Tetrahydroquinoline derivatives and tricyclic tetrahydroquinoline combinatorial libraries The present invention relates to novel tricyclic tetrahydroquinoline compounds of the following formula, libraries containing such compounds, and to the generation of such combinatorial libraries composed of such compounds: ##STR1## wherein R | 07/20/1999 |
| 5922878 | Amino acid derivatives, processes for preparing them and pharmaceutical compositions containing these compounds The invention relates to new amino acid derivatives of general formula I ##STR1## and the pharmaceutically acceptable salts thereof, wherein the group R2 is ##STR2## and R1, A, G, Y, Z and m have the meanings given in the ... | 07/13/1999 |
| 5854274 | Tricyclic heterocyclic sulfonamide and sulfonic ester derivatives Novel tricyclic heterocyclic sulfonamide derivatives and sulfonic ester derivatives which have excellent antitumor activity and are represented by the following general formula (I) and processes for producing the same are provided. The present sulfonamide... | 12/29/1998 |
| 5712397 | Amino acid derivatives, processes for preparing them and pharmaceutical compositions containing these compounds The invention relates to new amino acid derivatives of general formula I ##STR1## and the pharmaceutically acceptable salts thereof, wherein the group R2 is ##STR2## and R1, A, G, Y, Z and m have the meanings given in the ... | 01/27/1998 |
| 5710163 | Benzof!quinolinones This invention relates to hexa- and octahydrobenzof!quinolin-3-ones, pharmaceutical formulations containing those compounds and methods of their use as steroid 5-reductase inhibitors.... | 01/20/1998 |
| 5698550 | Tetralin and chroman derivatives useful in the treatment of asthma, arthritis and related diseases Compounds of the formula ##STR1## wherein R is an optionally substituted heteroaryl group such as 2-chromanyl, 2-pyridyl or 5-fluoro-2-benzothiazoyl; X is O, S or (CH2)m ; R1 is phenyl or pyridyl, optionally substituted by... | 12/16/1997 |
| 5690906 | Dopamine D-3 and serotonin (5-HT1A) receptor ligands and imaging agents Tetralin derivatives, such as 7-hydroxy-2-(N-n-propyl-N-3 '-iodo-2'-propenyl)-amino!tetralin and 8-hydroxy-2-(N-n-propyl-N-3 '-iodo-2'-propenyl)amino-tetralin, are disclosed which have affinity and specificity for dopamine D-3 and/or serotonin 5-HT1A... | 11/25/1997 |
| 5670512 | Benzo F! quinolinones This invention relates to hexa- and octaahydrobenzof!quinolin-3-ones, pharmaceutical formulations containing those compounds and methods of their use as steroid 5-reductase inhibitors.... | 09/23/1997 |
| 5663344 | Method for the synthesis of huperzine A and analogs thereof and compounds useful therein The present invention relates to a method for the synthesis of certain bridged fused ring pyridines. Such bridged fused ring pyridines can be converted to huperzine A and analogs of huperzine A. The present invention also covers such bridged fused ring py... | 09/02/1997 |
| 5635197 | Treatment and prevention of prostatic cancer metastasis A series of benzoquinolin-3-ones are pharmaceuticals effective in preventing the development of prostatic cancer, or preventing or treating the metastasis to bone of prostatic cancer.... | 06/03/1997 |
| 5629007 | Method of preventing prostatic cancer development A series of benzoquinolin-3-ones are pharmaceuticals effective in preventing the development of prostatic cancer, or preventing or treating the metastasis to bone of prostatic cancer.... | 05/13/1997 |
| 5624933 | Process for the preparation of a 6-fluoro-2-halo-quinoline Method of preparation of 6-fluoro-2-halogen quinoline of general formula (I) wherein R is a hydrogen atom or an alkyl radical and Hal and Hal' are identical or different halogen atoms. The invention is characterized in that a halogenating agent is made to... | 04/29/1997 |
| 5623080 | Fluorone and pyronin Y derivatives A compound of the formula (I) or (II): ##STR1## where R1, R2, R5 and R6 are the same or different and represent a hydrogen atom or a halogen atom and R1 and R2 may combine to form a ri... | 04/22/1997 |
| 5622962 | 5-reductase inhibitors A series of benzoquinolin-3-ones are pharmaceuticals effective in treating conditions consequent on both Type I and Type II 5-reductase.... | 04/22/1997 |
| 5622961 | 5-reductase inhibitors A series of benzoquinolin-3-ones are pharmaceuticals effective in treating conditions consequent on both Type I and Type II 5-reductase.... | 04/22/1997 |
| 5574160 | Syntheis of benzoquinolinones A 1-pot process for preparing 10b-methyl-3-oxo-benzo[f] quinolines.... | 11/12/1996 |
